Pregnancy Loss Clinical Trial
Official title:
Substituted Frozen Embryo Transfer Cycles With GnRH-agonist Supplementation
Verified date | June 2020 |
Source | Regionshospitalet Viborg, Skive |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The aim of this study is to compare two FET protocols by modifying the substituted FET cycle
in order to maintain a higher ongoing positive pregnancy rate and thus reduce the early
pregnancy loss.
Hypothesis: adding GnRH-agonist to the substituted cycle in FET treatment reduces the early
pregnancy loss.
Status | Completed |
Enrollment | 287 |
Est. completion date | April 2020 |
Est. primary completion date | April 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years to 45 Years |
Eligibility |
Inclusion Criteria: - Endometrial thickness = 7 mm after stimulation - 18-45 years - IVF/ICSI fertilisation - BMI > 18,5 <30 kg/m2 - cycle length 25-34 days Exclusion Criteria: - endometrial thickness < 7 mm or no triple layer endometrium and/or functional follicles - Uterine abnormality - Chronic medical disease - oocyte donation cycles |
Country | Name | City | State |
---|---|---|---|
Denmark | IVF syd | Fredericia | |
Denmark | Fertility Clinic Regional Hospital Skive | Skive |
Lead Sponsor | Collaborator |
---|---|
Peter Humaidan |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Luteal progesterone levels | 7th week of gestation | ||
Primary | Pregnancy loss rate | Primary outcome is avaible after 12th week of gestational. | ||
Secondary | Pregnancy rate | 14 days after embryo transfer. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT00954811 -
Luteal Supplementation With Rec-LH After GnRH-agonist Triggering in In Vitro (IVF)
|
Phase 4 | |
Completed |
NCT00194844 -
Couples Miscarriage Healing Project:Randomized Trial
|
Phase 1/Phase 2 | |
Completed |
NCT03712683 -
Thyroxin in Subclinical Hypothyroidism
|
N/A | |
Not yet recruiting |
NCT05039853 -
Improving Mental Health Following Early PREgnancy Loss Using a Brief Cognitive Task
|
N/A | |
Withdrawn |
NCT00771511 -
Cervical Capsaicin for Labor Induction and Pain Relief
|
Phase 4 | |
Terminated |
NCT03100123 -
AntiPhospholipid Syndrome Low-molecular-weight Heparin Pregnancy Loss Evaluation: The Pilot Study
|
Early Phase 1 | |
Active, not recruiting |
NCT05108675 -
Microbiome and Malnutrition in Pregnancy (MMiP)
|
||
Completed |
NCT03585023 -
Infections and Pregnancy Loss: Correlation Between Abortion and Silent Infections.
|
||
Completed |
NCT05430633 -
Laparoscopic Versus Open Appendectomy in Pregnancy
|
||
Completed |
NCT00583635 -
Early Pregnancy Antioxidant Supplementation in the Prevention of Preeclampsia
|
N/A | |
Active, not recruiting |
NCT04360564 -
RPL: Interval to Live Birth and Adverse Perinatal Outcomes
|
||
Not yet recruiting |
NCT06385444 -
IVF Failure and Pregnancy Loss on Couples' Psychological Stress
|
||
Completed |
NCT03433989 -
ACTRAMAT-D: Impact of Post-Traumatic Stress Disorder After Pregnancy Loss After 12 Weeks of Gestation
|
N/A | |
Terminated |
NCT03354832 -
In-utero Death and Birth Mortality in Reunion Island
|
||
Recruiting |
NCT05284305 -
Desmoid Tumor and Pregnancy: Effect of Pregnancy on Disease Control and Effect of Diagnosis on Pregnancy History.
|
||
Completed |
NCT03948022 -
Luteal Support in Frozen-Thawed Embryo Transfer Cycles
|
Phase 4 | |
Active, not recruiting |
NCT05418140 -
Adenomyosis and Pregnancy Outcomes in Women Undergoing Assisted Reproductive Technology Treatment
|
||
Recruiting |
NCT06408181 -
APPLE: Aspirin to Prevent Pregnancy Loss and Preeclampsia
|
Phase 3 | |
Completed |
NCT05344144 -
EFT and Music on Psychological Development, Well-Being Status and Cortisol Level in Pregnant Women
|
N/A | |
Recruiting |
NCT05322252 -
Simultaneous Mifepristone and Misoprostol Versus Misoprostol Alone for Induction of Labor of Nonviable Second Trimester Pregnancy: a Pilot Randomized Controlled Trial
|
Phase 4 |